| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CMO &Head of Late-stage Dev. | EVP &Chief Medical Officer
1 company
Stein Steven H serves as a CMO &Head of Late-stage Dev. at INCY. Across recent SEC filings that breaks down to 0 buys and 25 sells.
Historically, Stein Steven H's trades have earned a middling insider score of 51/100 across 11 rated trades. Over a 12-month horizon, 14.3% of those trades were profitable, with an average 12-month return of -29.8%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2023 | INCY Incyte Corp | EVP &Chief Medical Officer | Sell10b5-1 | 21,511 | $63.28 | $1,361,216.08 | -18.1% | -18.1% | +2.2% | |
| Jan 4, 2023 | INCY Incyte Corp | EVP &Chief Medical Officer | Sell | 28,399 | $79.78 | $2,265,672.22 | -20.7% | -8.1% | -15.8% | |
| Jan 25, 2021 | INCY Incyte Corp | EVP &Chief Medical Officer | Sale+OE | 3,795 | $100.00 | $379,500.00 | -3.1% | - | - | |
| Jul 16, 2020 | INCY Incyte Corp | EVP &Chief Medical Officer | Sell | 766 | $103.83 | $79,533.78 | -0.8% | - | - | |
| Jul 8, 2020 | INCY Incyte Corp | EVP &Chief Medical Officer | Sale+OE | 14,769 | $109.52 | $1,617,547.81 | -13.2% | - | - | |
| Jul 6, 2020 | INCY Incyte Corp | EVP &Chief Medical Officer | Sale+OE | 36,124 | $107.25 | $3,874,171.42 | -26.4% | - | - | |
| Jun 24, 2019 | INCY Incyte Corp | EVP &Chief Medical Officer | Sell | 8,357 | $87.96 | $735,081.72 | -43.6% | - | - |